Risk of Infection Associated With Subsequent Biologic Agent Use After Rituximab: Results From a National Rheumatoid Arthritis Patient Registry

OBJECTIVE: To assess whether the time between the last rituximab infusion and initiation of a different biologic agent influenced infection risk in patients with rheumatoid arthritis (RA). METHODS: Patients with RA who newly initiated rituximab within the Consortium of Rheumatology Researchers of No...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrold, Leslie R., Reed, George W., Karki, Chitra, Magner, Robert, Shewade, Ashwini, John, Ani, Kremer, Joel M., Greenberg, Jeffrey D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5132134/
https://www.ncbi.nlm.nih.gov/pubmed/27111064
http://dx.doi.org/10.1002/acr.22912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5132134/
https://www.ncbi.nlm.nih.gov/pubmed/27111064
http://dx.doi.org/10.1002/acr.22912

Ejemplares similares